Walleye Capital
FDMT icon

Walleye Capital’s 4D Molecular Therapeutics FDMT Stock Holding History

Walleye Capital’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,762
Closed -$381K – 4592
2025
Q4 		$381K Buy
+50,762
New +$515K ﹤0.01% 3128
2024
Q4 		– Sell
-84,322
Closed -$912K – 5073
2024
Q3 		$912K Buy
+84,322
New +$1.4M 0.01% 2747
2023
Q1 		– Sell
-16,919
Closed -$376K – 4187
2022
Q4 		$376K Buy
+16,919
New +$261K 0.01% 1640
2022
Q3 		– Sell
-28,068
Closed -$196K – 3372
2022
Q2 		$196K Buy
+28,068
New +$273K 0.01% 1530
2021
Q3 		– Sell
-12,205
Closed -$294 – 1662
2021
Q2 		$294 Buy
+12,205
New +$374K 0.01% 954

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return